MeSH tree: E04.936.225.687
The brain's mechanisms for repairing injuries caused by trauma or degenerative diseases are not yet known in detail. Now, a study from the University of Barcelona describes a new strategy based on stem cell therapy that could ...
Oct 14, 2025
0
40
Adding genomic sequencing to newborn blood screening would detect hundreds of additional childhood conditions, providing much earlier diagnosis and treatment, according to a new study. A baby's genome, which stays with them ...
Oct 9, 2025
0
13
The European Society for Blood and Marrow Transplantation (EBMT) has released its ninth special report on indications for hematopoietic cell transplantation (HCT) and chimeric antigen receptor T-cell (CAR-T) therapy. The ...
Oct 2, 2025
0
13
When someone has a stroke—a leading worldwide cause of death and disability—time is of the essence. Almost nine out of 10 cases are ischemic strokes, caused by restricted blood flow in the brain, and the current gold-standard ...
Sep 16, 2025
0
139
New research from the University of Minnesota Medical School is providing important insights into how COVID-19 persists in cancer patients even long after testing positive. The findings were recently published in iScience.
Sep 10, 2025
0
14
University at Buffalo researchers and collaborators have completed a series of studies that reveal how much painful mouth sores known as oral mucositis increase infection risks in stem cell transplant patients and how artificial ...
Sep 8, 2025
0
11
Transplanting hematopoietic stem cells from healthy individuals is one of the possible treatments for blood cancers. In Switzerland, it involves nearly 300 patients per year. However, nearly half of transplants fail, mainly ...
Sep 3, 2025
0
13
Researchers at Karolinska Institutet have identified a vulnerability in certain blood cancer cells that makes it possible to eliminate the cancer cells with a drug, without harming healthy cells. The study is published in ...
Sep 2, 2025
0
28
Fewer than half of people diagnosed with a subtype of myeloid/lymphoid neoplasms are alive one year later. A multicenter Phase II trial, called FIGHT-203, led by Stanford Medicine, has led to FDA approval of a new drug treatment.
Aug 28, 2025
0
24
Most folks probably think of gene mutations as something people are born with, but genes can also change later in life, sometimes making people sick.
Aug 18, 2025
0
18
